Larvol Delta - BrainChild-Bio-Inc-to-Clinically-Advance-BCB276-an-Autologous-B7H3-Targeting-CAR-Tcell-Therapy-for-Incurable-Pediatric-Brain-Tumors

BCB-276 - BrainChild Bio

https://www.businesswire.com/news/home/20250106302628/en/BrainChild-Bio-Inc.-to-Clinically-Advance-BCB-276-an-Autologous-B7-H3-Targeting-CAR-T-cell-Therapy-for-Incurable-Pediatric-Brain-Tumors

Jan 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev